<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Publications | Tissuepathology.com</title>
	<atom:link href="https://tissuepathology.com/category/medical-research/publications/feed/" rel="self" type="application/rss+xml" />
	<link>https://tissuepathology.com</link>
	<description>Educational and informative</description>
	<lastBuildDate>Thu, 27 Aug 2026 13:04:38 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png</url>
	<title>Publications | Tissuepathology.com</title>
	<link>https://tissuepathology.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications</title>
		<link>https://tissuepathology.com/2026/08/27/tempus-study-published-in-nature-medicine-demonstrates-best-in-class-performance-of-prism2-across-diagnostic-and-prognostic-applications/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Thu, 27 Aug 2026 13:04:38 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[Publications]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Diagnostics Prognostics]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Nature Medicine]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Publication]]></category>
		<category><![CDATA[Tempus AI]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24640</guid>

					<description><![CDATA[<p>Tempus’ multimodal foundation model offers diagnostic-grade precision for cancer detection and unlocks broader applications predicting biomarker status and patient prognosis CHICAGO, August 4, 2026 — Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced study results demonstrating that PRISM2, a multimodal slide-level pathology [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/08/27/tempus-study-published-in-nature-medicine-demonstrates-best-in-class-performance-of-prism2-across-diagnostic-and-prognostic-applications/">Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Lunit study shows higher HER2 diagnostic agreement between AI and pathologists</title>
		<link>https://tissuepathology.com/2025/12/23/lunit-study-shows-higher-her2-diagnostic-agreement-between-ai-and-pathologists/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Tue, 23 Dec 2025 13:28:43 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Publications]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[bile duct cancer]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[HER2]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Laboratory Investigation]]></category>
		<category><![CDATA[Lunit]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[USCAP]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24131</guid>

					<description><![CDATA[<p>Lunit said Tuesday that it has published research showing that its AI biomarker platform, Lunit SCOPE, can improve HER2 (human epidermal growth factor receptor 2) diagnosis in advanced bile duct cancer. The study was published in Laboratory Investigation, the official journal of the United States and Canadian Academy of Pathology (USCAP) (Impact Factor 4.2). Biliary tract [&#8230;]</p>
The post <a href="https://tissuepathology.com/2025/12/23/lunit-study-shows-higher-her2-diagnostic-agreement-between-ai-and-pathologists/">Lunit study shows higher HER2 diagnostic agreement between AI and pathologists</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Journal of Clinical Microbiology Publishes Article on ARUP Validation of AI for Parasite Detection</title>
		<link>https://tissuepathology.com/2025/11/03/journal-of-clinical-microbiology-publishes-article-on-arup-validation-of-ai-for-parasite-detection/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 03 Nov 2025 16:10:34 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[Publications]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[ARUP Laboratories]]></category>
		<category><![CDATA[convolutional neural network]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Journal of Clinical Microbiology]]></category>
		<category><![CDATA[Parasite Detection]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Techcyte]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24020</guid>

					<description><![CDATA[<p>October 21, 2025 Salt Lake City—ARUP Laboratories today announced the publication of an article in the Journal of Clinical Microbiology describing the company’s validation of a deep convolutional neural network (CNN) to detect parasites in concentrated wet mounts of stool. For decades, detection of gastrointestinal parasites has relied on traditional microscopy, which is a labor-intensive process [&#8230;]</p>
The post <a href="https://tissuepathology.com/2025/11/03/journal-of-clinical-microbiology-publishes-article-on-arup-validation-of-ai-for-parasite-detection/">Journal of Clinical Microbiology Publishes Article on ARUP Validation of AI for Parasite Detection</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Could Lithium Explain — and Treat — Alzheimer’s Disease?</title>
		<link>https://tissuepathology.com/2025/08/08/could-lithium-explain-and-treat-alzheimers-disease/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 08 Aug 2025 12:07:23 +0000</pubDate>
				<category><![CDATA[General Healthcare News]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Publications]]></category>
		<category><![CDATA[Alzheimer’s]]></category>
		<category><![CDATA[lithium orotate]]></category>
		<category><![CDATA[Nature]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=23829</guid>

					<description><![CDATA[<p>Study: Lithium loss ignites Alzheimer’s, but lithium compound can reverse disease in mice What is the earliest spark that ignites the memory-robbing march of Alzheimer’s disease? Why do some people with Alzheimer’s-like changes in the brain never go on to develop dementia? These questions have bedeviled neuroscientists for decades. Now, a team of researchers at Harvard [&#8230;]</p>
The post <a href="https://tissuepathology.com/2025/08/08/could-lithium-explain-and-treat-alzheimers-disease/">Could Lithium Explain — and Treat — Alzheimer’s Disease?</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Mount Sinai: Study Shows How AI Could Help Pathologists Match Cancer Patients to the Right Treatments—Faster and More Efficiently</title>
		<link>https://tissuepathology.com/2025/07/14/mount-sinai-study-shows-how-ai-could-help-pathologists-match-cancer-patients-to-the-right-treatments-faster-and-more-efficiently/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 14 Jul 2025 10:53:42 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[Publications]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Icahn School of Medicine]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Lung Cancer]]></category>
		<category><![CDATA[Memorial Sloan Kettering Cancer Center]]></category>
		<category><![CDATA[Mount Sinai]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Research]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=23775</guid>

					<description><![CDATA[<p>Mount Sinai: Real-time trial shows AI could speed cancer care New York, NY  (July 09, 2025) A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how doctors determine the best treatment for cancer patients—by enhancing how [&#8230;]</p>
The post <a href="https://tissuepathology.com/2025/07/14/mount-sinai-study-shows-how-ai-could-help-pathologists-match-cancer-patients-to-the-right-treatments-faster-and-more-efficiently/">Mount Sinai: Study Shows How AI Could Help Pathologists Match Cancer Patients to the Right Treatments—Faster and More Efficiently</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>From Cureus Journal of Medicine: A Pilot Study of Breast Cancer Histopathological Image Classification Using Google Teachable Machine: A No-Code Artificial Intelligence Approach</title>
		<link>https://tissuepathology.com/2025/07/07/from-cureus-journal-of-medicine-a-pilot-study-of-breast-cancer-histopathological-image-classification-using-google-teachable-machine-a-no-code-artificial-intelligence-approach/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 07 Jul 2025 12:14:17 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Data Management]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Publications]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[Cureus Journal of Medicine]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Google Teachable Machine]]></category>
		<category><![CDATA[histopathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Image Classification]]></category>
		<category><![CDATA[No Code]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Pilot Study]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=23757</guid>

					<description><![CDATA[<p>From the Cureus Journal of Medicine, researchers publish a pilot study of breast cancer Histopathological Image Classification Using Google Teachable Machine. Read the Abstract below. Abstract Introduction Breast cancer remains a major global cause of cancer-related mortality, where histopathology serves as the diagnostic cornerstone. However, inter-observer variability and increasing diagnostic workload necessitate innovative solutions. This [&#8230;]</p>
The post <a href="https://tissuepathology.com/2025/07/07/from-cureus-journal-of-medicine-a-pilot-study-of-breast-cancer-histopathological-image-classification-using-google-teachable-machine-a-no-code-artificial-intelligence-approach/">From Cureus Journal of Medicine: A Pilot Study of Breast Cancer Histopathological Image Classification Using Google Teachable Machine: A No-Code Artificial Intelligence Approach</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
